Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
10592studies shown
Showing 5,629-5,640 of 10,592
Drug study icon
TerminatedNCT03121586

Extension Study of Pimavanserin for the Adjunctive Treatment of Schizophrenia

This study exists to understand how the medication Pimavanserin holds up over time after the earliest research stage. For people living with Schizophrenia, that matters because care needs to work in daily life, not just in theory.

In United States
SchizophreniaDrugOver 18 Years
Countries
United States, Canada, Argentina, ...
Sponsor
ACADIA Pharmaceuticals Inc.
Condition
Schizophrenia
Drug study icon
TerminatedNCT01121536

Safety and Efficacy of Armodafinil Treatment for depression

This study was terminated in the United States, in Australia, in France, .... It is testing safety and Efficacy of Armodafinil Treatment for depression.

In United States
Bipolarity, DepressionDrugFrom 18 Years to 65 Years
Countries
United States, Australia, France, ...
Sponsor
Cephalon
Condition
Bipolarity, Depression
Behavioral study icon
CompletedNCT02154685

Extinction Updating in Reconsolidation

This summary needs review. Please check the official study record and contact the research team for details.

In United States
AddictionBehavioralFrom 18 Years to 65 Years
Countries
United States
Sponsor
Medical University of South Carolina
Condition
Addiction
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.